IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM antibodies and to allow for the rapid development of engineered therapeutic antibodies. The firm’s product pipeline includes IGM-2323, which is a CD20 x CD3 bispecific IgM antibody designed to treat patients with B cell Non-Hodgkin's lymphoma and other B cell malignancies, IGM-8444, which is an IgM antibody targeting Death Receptor 5 for the treatment of patients with solid and hematologic malignancies, and IGM-7354, which will target the delivery of IL-15 with the goal of inducing immune cell stimulation and proliferation. The company was founded in 2010 and is headquartered in Mountain View, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
149
Frequently Asked Questions
What is Market Cap of IGM Biosciences Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. IGM Biosciences Inc market cap is $78.71M.
What is the 52-week high for IGM Biosciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. IGM Biosciences Inc 52 week high is $22.50 as of September 12, 2025.
What is the 52-week low for IGM Biosciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. IGM Biosciences Inc 52 week low is $0.92 as of September 12, 2025.
What is IGM Biosciences Inc stock price today?
IGM Biosciences Inc stock price today is $1.29.
What was IGM Biosciences Inc stock price yesterday?
IGM Biosciences Inc stock price yesterday was $1.30.
What is the PE ratio of IGM Biosciences Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. IGM Biosciences Inc’s P/E ratio is -1.39.
What is the Price-to-Book ratio of IGM Biosciences Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. IGM Biosciences Inc P/B ratio is 0.7574.
What is the 50-day moving average of IGM Biosciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. IGM Biosciences Inc 50-day moving average is $1.27.